ProfileGDS4132 / 219476_at
TitlePPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
OrganismHomo sapiens


pretreatment pioglitazone GSM201542 GSM201543 GSM201544 GSM201545 GSM201829 GSM201830 GSM201831 GSM201832 GSM201833 GSM201834 GSM201835 GSM201836 GSM201837 GSM201838 GSM201839 GSM201840 GSM201841 GSM201842 GSM201843 GSM201844 23% 22% 44% 68% 25% 24% 45% 18% 80% 65% 88% 90% 62% 41% 89% 94% 83% 86% 88% 83% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM201542Muscle PCOS pioglitazone 10154.213823
GSM201543Muscle PCOS pioglitazone 12142.951922
GSM201544Muscle PCOS pioglitazone 161116.63344
GSM201545Muscle PCOS pioglitazone 201212.50668
GSM201829Muscle PCOS pioglitazone 23162.309925
GSM201830Muscle PCOS pioglitazon 25157.578424
GSM201831Muscle PCOS pioglitazone 271118.41545
GSM201832Muscle PCOS pioglitazone 3139.338918
GSM201833Muscle PCOS pioglitazone 41272.48480
GSM201834Muscle PCOS pioglitazone 81187.06965
GSM201835Muscle PCOS after pioglitazone 102400.31588
GSM201836Muscle PCOS after pioglitazone 122439.12690
GSM201837Muscle PCOS after pioglitazone 162158.5362
GSM201838Muscle PCOS after pioglitazone 20295.690141
GSM201839Muscle PCOS after pioglitazone 232421.82589
GSM201840Muscle PCOS after pioglitazone 252678.51594
GSM201841Muscle PCOS after pioglitazone 272295.12183
GSM201842Muscle PCOS after pioglitazone 32332.71686
GSM201843Muscle PCOS after pioglitazone 42397.30588
GSM201844Muscle PCOS after pioglitazone 82322.42883